These data indicate that CCN1 is a mediator of IL-1β production in psoriasis and plays a critical role in regulating inflammation in psoriasis, suggesting that CCN1 could be a potential target for clinical treatment of inflammatory and autoimmune diseases, such as psoriasis. Here, CCN1 is linked to autoimmune disease.